Risultati di ricerca
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
- Solutions
ICON experts can help to implement patient-centric,...
- Sectors
Sectors - ICON plc | Clinical Research Organisation (CRO)...
- Therapeutics
Driving paediatric clinical research forward and protecting...
- Insights
Digital Disruption Technologies that accelerate and improve...
- News & Events
News & Events - ICON plc | Clinical Research Organisation...
- About ICON
ICON has been recognised as one of the world’s leading...
- Careers
ICON Careers. We encourage our people to seize the...
- Contact
Contact - ICON plc | Clinical Research Organisation (CRO)...
- Solutions
ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.
Driving paediatric clinical research forward and protecting kids through research—not from it. ICON has been recognised for having 'exceeded customer expectations’ for ‘therapeutic expertise’ in the 2024 CRO Leadership Awards. ICON was the most awarded CRO across over 20 performance metrics.
Choosing ICON means a decision you can feel good about – we’ve been an integral part of bringing more than 70 life-changing drugs to market. For over 40 years, we’ve studied drugs in a variety of categories, from cancer to rare diseases.
6 giorni fa · The ICON Digital Platform is an end-to-end solution to enable patient services throughout the clinical trial. Its ease of use supports patient centricity and reduces the barriers to trial participation thus enhancing equity, diversity and inclusion.
Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs, providing true transparency across all areas of a study.
For the sixth consecutive year, ICON has been named a recipient of the CRO Leadership Award. In 2023, ICON was pleased to receive the CRO Leadership awards in five categories; Capabilities, Compatibility, Expertise, Quality and Reliability, spanning Big Pharma, Small Pharma and Overall segments.
